Shanghai Pioneer Holding Ltd (HKG:1345)

Market Cap	2.63B +0.4%
Revenue (ttm)	1.43B -16.2%
Net Income	127.29M -24.6%
EPS	0.11 -23.7%
Shares Out	1.16B
PE Ratio	20.56
Forward PE	n/a
Dividend	0.12 (5.41%)
Ex-Dividend Date	Jun 3, 2026

Volume	40,000
Open	2.260
Previous Close	2.290
Day's Range	2.260 - 2.270
52-Week Range	1.590 - 2.400
Beta	-0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 5, 2026

About Shanghai Pioneer Holding

Shanghai Pioneer Holding Ltd, an investment holding company, engages in marketing, promotion, and channel management of pharmaceutical products and medical devices primarily in the People’s Republic of China. It offers pharmaceutical products for ophthalmology, pain management, cardiovascular, immunology, gynecology, gastroenterology, and other therapeutic areas; and medical devices, including ophthalmology, orthopedics, odontology, and wound care products. The company also engages in the sale of ancillary tools, and imported in-licensed prescr...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1996
• Employees: 364
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1345

Financial Performance

In 2025, Shanghai Pioneer Holding's revenue was 1.28 billion, a decrease of -16.17% compared to the previous year's 1.53 billion. Earnings were 114.38 million, a decrease of -24.56%.

Financial numbers in CNY